NBR2 and hepatoblastoma: TCF7 has been defined as the target molecule of miR-22 and NBR2, which is localized in both the cytoplasm and nucleus, aggravates hepatoblastoma cell malignancy by sponging miR-22 under conditions of glucose starvation, thereby counteracting miR-22-induced TCF7 repression (Figure 4) (60).